Achieve Life Sciences, Inc. Fair Value Adjustment of Warrants
Achieve Life Sciences, Inc. (ACHV) reported Fair Value Adjustment of Warrants of $48.53 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-11
- Achieve Life Sciences, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was $48.53M.
- Achieve Life Sciences, Inc. fair value adjustment of warrants for the quarter ending 2017-12-31 was -$39.00K.
- Achieve Life Sciences, Inc. fair value adjustment of warrants for the quarter ending 2017-09-30 was -$111.00K.
- Achieve Life Sciences, Inc. fair value adjustment of warrants for the quarter ending 2017-06-30 was -$66.00K, a 112.38% decline year-over-year.
- Achieve Life Sciences, Inc. fair value adjustment of warrants for fiscal 2017 was -$150.00K.
- Achieve Life Sciences, Inc. fair value adjustment of warrants for fiscal 2016 was -$873.00K.
- Achieve Life Sciences, Inc. fair value adjustment of warrants for fiscal 2015 was -$1.90M.
- Achieve Life Sciences, Inc. fair value adjustment of warrants for fiscal 2014 was -$3.74M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $48.53M 10-Q · filed 2026-08-11 | $48.53M 10-Q · filed 2026-08-11 | ||
| 2017-12-31 | -$39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$150.00K derived: sum of 2 quarters · filed 2020-03-13 | -$216.00K derived: sum of 3 quarters · filed 2020-03-13 | -$150.00K 10-K · filed 2020-03-13 |
| 2017-09-30 | -$111.00K 10-Q · filed 2018-11-07 | -$177.00K derived: sum of 2 quarters · filed 2018-11-07 | -$111.00K 10-Q · filed 2018-11-07 | -$347.00K derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | -$66.00K 10-Q · filed 2017-07-31 | -$118.00K 10-Q · filed 2017-07-31 | -$236.00K derived: sum of 3 quarters · filed 2017-07-31 | -$857.00K derived: sum of 4 quarters · filed 2017-07-31 |
| 2017-03-31 | -$52.00K 10-Q · filed 2017-05-15 | -$170.00K derived: sum of 2 quarters · filed 2017-05-15 | -$791.00K derived: sum of 3 quarters · filed 2017-05-15 | -$258.00K derived: sum of 4 quarters · filed 2017-07-31 |
| 2016-12-31 | -$118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$739.00K derived: sum of 2 quarters · filed 2017-02-23 | -$206.00K derived: sum of 3 quarters · filed 2017-07-31 | -$873.00K 10-K · filed 2017-02-23 |
| 2016-09-30 | -$621.00K 10-Q · filed 2016-11-10 | -$88.00K derived: sum of 2 quarters · filed 2017-07-31 | -$755.00K 10-Q · filed 2016-11-10 | -$2.49M derived: sum of 4 quarters · filed 2017-07-31 |
| 2016-06-30 | $533.00K 10-Q · filed 2017-07-31 | -$134.00K 10-Q · filed 2017-07-31 | -$1.86M derived: sum of 3 quarters · filed 2017-07-31 | -$2.00M derived: sum of 4 quarters · filed 2017-07-31 |
| 2016-03-31 | -$667.00K 10-Q · filed 2017-05-15 | -$2.40M derived: sum of 2 quarters · filed 2017-05-15 | -$2.53M derived: sum of 3 quarters · filed 2017-05-15 | -$2.10M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$1.86M derived: sum of 2 quarters · filed 2017-02-23 | -$1.43M derived: sum of 3 quarters · filed 2017-02-23 | -$1.90M 10-K · filed 2017-02-23 |
| 2015-09-30 | -$131.00K 10-Q · filed 2016-11-10 | $298.00K derived: sum of 2 quarters · filed 2016-11-10 | -$166.00K 10-Q · filed 2016-11-10 | -$1.14M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $429.00K 10-Q · filed 2016-08-04 | -$35.00K 10-Q · filed 2016-08-04 | -$1.01M derived: sum of 3 quarters · filed 2017-02-23 | -$3.88M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | -$465.00K 10-Q · filed 2016-05-12 | -$1.44M derived: sum of 2 quarters · filed 2017-02-23 | -$4.31M derived: sum of 3 quarters · filed 2017-02-23 | -$4.93M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | -$973.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$3.85M derived: sum of 2 quarters · filed 2017-02-23 | -$4.46M derived: sum of 3 quarters · filed 2017-02-23 | -$3.74M 10-K · filed 2017-02-23 |
| 2014-09-30 | -$2.87M 10-Q · filed 2014-10-30 | -$3.49M derived: sum of 2 quarters · filed 2015-11-12 | -$2.77M 10-Q · filed 2015-11-12 | -$3.10M derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-06-30 | -$615.00K 10-Q · filed 2015-08-13 | $106.00K 10-Q · filed 2015-08-13 | -$228.00K derived: sum of 3 quarters · filed 2016-03-09 | -$767.00K derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-03-31 | $721.00K 10-Q · filed 2015-05-14 | $387.00K derived: sum of 2 quarters · filed 2016-03-09 | -$152.00K derived: sum of 3 quarters · filed 2016-03-09 | -$1.05M derived: sum of 4 quarters · filed 2016-03-09 |
| 2013-12-31 | -$334.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$873.00K derived: sum of 2 quarters · filed 2016-03-09 | -$1.77M derived: sum of 3 quarters · filed 2016-03-09 | -$3.21M 10-K · filed 2016-03-09 |
| 2013-09-30 | -$539.00K 10-Q · filed 2014-10-30 | -$1.44M derived: sum of 2 quarters · filed 2014-10-30 | -$2.87M 10-Q · filed 2014-10-30 | -$4.81M derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-06-30 | -$901.00K 10-Q · filed 2014-08-07 | -$2.33M 10-Q · filed 2014-08-07 | -$4.27M derived: sum of 3 quarters · filed 2015-03-26 | -$6.58M derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-03-31 | -$1.43M 10-Q · filed 2014-04-30 | -$3.37M derived: sum of 2 quarters · filed 2015-03-26 | -$5.68M derived: sum of 3 quarters · filed 2015-03-26 | -$7.32M derived: sum of 4 quarters · filed 2015-03-26 |
| 2012-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | -$4.25M derived: sum of 2 quarters · filed 2015-03-26 | -$5.89M derived: sum of 3 quarters · filed 2015-03-26 | -$4.46M 10-K · filed 2015-03-26 |
| 2012-09-30 | -$2.31M 10-Q · filed 2013-11-07 | -$3.95M derived: sum of 2 quarters · filed 2013-11-07 | -$2.52M 10-Q · filed 2013-11-07 | |
| 2012-06-30 | -$1.64M 10-Q · filed 2013-08-08 | -$214.00K 10-Q · filed 2013-08-08 | ||
| 2011-12-31 | -$7.39M 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |